Technology
Autoimmunity BioSolutions – SUCCESS PAGE – May 27, 2026
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
A networking reception in an informal setting to foster connections and cultivate mutually beneficial relationships
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.